CALICETI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.601
AS - Asia 8.282
EU - Europa 4.896
AF - Africa 2.116
SA - Sud America 1.746
OC - Oceania 190
Continente sconosciuto - Info sul continente non disponibili 94
Totale 36.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.596
SG - Singapore 3.025
CN - Cina 1.572
BR - Brasile 1.049
HK - Hong Kong 999
IT - Italia 901
VN - Vietnam 547
FI - Finlandia 524
DE - Germania 416
UA - Ucraina 283
FR - Francia 260
RU - Federazione Russa 248
SE - Svezia 224
PL - Polonia 199
GB - Regno Unito 193
NL - Olanda 157
IN - India 137
AR - Argentina 132
TR - Turchia 114
IE - Irlanda 97
IQ - Iraq 90
KR - Corea 90
IR - Iran 89
MX - Messico 86
ES - Italia 83
ZA - Sudafrica 82
JP - Giappone 81
PK - Pakistan 81
ID - Indonesia 80
EC - Ecuador 78
AT - Austria 76
IL - Israele 75
CO - Colombia 74
KE - Kenya 68
MA - Marocco 66
MY - Malesia 66
PY - Paraguay 66
BE - Belgio 65
RO - Romania 65
UZ - Uzbekistan 65
GF - Guiana Francese 64
CI - Costa d'Avorio 63
EG - Egitto 62
VE - Venezuela 62
BW - Botswana 61
CA - Canada 61
CM - Camerun 61
AO - Angola 60
BJ - Benin 60
GR - Grecia 60
SA - Arabia Saudita 60
BB - Barbados 59
MD - Moldavia 59
RS - Serbia 59
UY - Uruguay 59
YT - Mayotte 59
BZ - Belize 58
PT - Portogallo 58
DZ - Algeria 57
JO - Giordania 57
LY - Libia 57
NP - Nepal 57
AZ - Azerbaigian 56
BO - Bolivia 56
BY - Bielorussia 56
GN - Guinea 56
MR - Mauritania 56
LA - Repubblica Popolare Democratica del Laos 55
CG - Congo 54
CL - Cile 54
KG - Kirghizistan 54
PR - Porto Rico 54
SN - Senegal 54
TW - Taiwan 54
DO - Repubblica Dominicana 53
GE - Georgia 53
MU - Mauritius 53
PA - Panama 53
SI - Slovenia 53
TJ - Tagikistan 53
BG - Bulgaria 52
CR - Costa Rica 52
HU - Ungheria 52
ML - Mali 52
PE - Perù 52
PS - Palestinian Territory 52
SD - Sudan 52
UG - Uganda 52
AM - Armenia 51
BF - Burkina Faso 51
DK - Danimarca 51
GH - Ghana 51
HN - Honduras 51
ZM - Zambia 51
CU - Cuba 50
CV - Capo Verde 50
CW - ???statistics.table.value.countryCode.CW??? 50
CY - Cipro 50
ME - Montenegro 50
MZ - Mozambico 50
Totale 34.511
Salva come PNG Salva come JPEG
Città #
Fairfield 2.213
Woodbridge 2.011
Ashburn 1.631
Singapore 1.535
Houston 1.504
Ann Arbor 1.453
Chandler 1.396
Jacksonville 1.144
Hong Kong 955
Wilmington 849
Seattle 770
Cambridge 731
Beijing 483
Santa Clara 446
Boardman 431
Princeton 416
San Diego 264
Padova 218
Medford 201
Helsinki 181
Nanjing 177
Ho Chi Minh City 172
Bytom 122
Los Angeles 113
Dong Ket 107
Hanoi 97
Des Moines 95
Munich 94
São Paulo 85
New York 82
Milan 80
Roxbury 80
Dublin 79
Chicago 70
Guangzhou 64
Hebei 60
Abidjan 59
Tashkent 58
Cotonou 57
Nanchang 57
Nairobi 56
Shenyang 55
Amman 54
Bridgetown 54
Buffalo 54
Conakry 54
Dakar 54
Luanda 53
Baku 52
Montevideo 52
Nouakchott 51
Cayenne 50
Dushanbe 50
Havana 50
Kampala 50
Lusaka 50
Panama City 50
Vientiane 50
Bamako 49
Castries 48
Ulan Bator 48
Antananarivo 47
Hefei 47
Bishkek 45
Accra 44
Libreville 43
London 43
Niamey 43
Norwalk 43
Praia 43
Andorra la Vella 42
Podgorica 42
San José 42
Vienna 42
Maputo 41
Managua 40
Minsk 40
Nassau 40
Tripoli 40
Warsaw 40
Brazzaville 39
Changsha 39
Jinan 39
Willemstad 39
Gaborone 38
Harare 38
Kigali 38
Tbilisi 38
Noumea 37
Tokyo 37
Dili 36
Reykjavik 36
Tel Aviv 36
Yerevan 36
Djibouti 35
Mamoudzou 35
Phnom Penh 35
Riga 34
Rome 34
Belgrade 33
Totale 23.263
Salva come PNG Salva come JPEG
Nome #
1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma 260
A NEW PRODUCTION METHOD OF HIGH SPECIFIC ACTIVITY RADIONUCLIDES TOWARDS INNOVATIVE RADIOPHARMACEUTICALS: THE ISOLPHARM PROJECT 241
A comparative study of folate receptor-targeted doxorubicin delivery systems: Dosing regimens and therapeutic index 232
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway 222
Real-Time Label-Free Targeting Assessment and in Vitro Characterization of Curcumin-Loaded Poly-lactic-co-glycolic Acid Nanoparticles for Oral Colon Targeting 214
Preservation of Thrombolytic Activity of Urokinase Modified with Monomethoxypoly(ethylene glycol 210
Oligo-guanidyl targeted bioconjugates forming rod shaped polyplexes as a new nanoplatform for oligonucleotide delivery 209
A novel soluble supramolecular system for sustained rh-GH delivery 203
Physical PEGylation to Prevent Insulin Fibrillation 203
Nanovectors Design for Theranostic Applications in Colorectal Cancer 203
Control of targeting ligand display by pH-responsive polymers on gold nanoparticles mediates selective entry into cancer cells 201
Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation 200
Switching of macromolecular ligand display by thermoresponsive polymers mediates endocytosis of multi-conjugate nanoparticles 200
Novel Oligo-Guanidyl-PEG Carrier Forming Rod-Shaped Polyplexes 196
Recellularized colorectal cancer patient-derived scaffolds as in vitro pre-clinical 3D model for drug screening 196
Self-assembling nanocomposites for protein delivery: Supramolecular interactions between PEG-cholane and rh-G-CSF. 188
PH-Controlled Liposomes for Enhanced Cell Penetration in Tumor Environment 188
Accurate evaluation method of the polymer content in Monomethoxy(polyethylene glycol) modified proteins based on Amino acid analysis 182
A branched monomethoxypoly(ethylene glycol) for protein modification 180
Design, synthesis, and photophysical properties of pyrroloquinoline-based compounds showing strong blue fluorescence as potential dyes for biomedical applications 180
Site-selective protein glycation and PEGylation 179
Triblock copolymer nanovesicles for pH-responsive targeted delivery and controlled release of siRNA to cancer cells 178
Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells 178
A novel combined strategy for the physical PEGylation of polypeptides 176
In vitro and in vivo behavior of liposomes decorated with PEGs with different chemical features 175
Polyphosphazene membranes and microspheres in periodontal diseases and implant surgery 173
Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers 173
Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury 172
Enhanced selective sonosensitizing efficacy of ultrasound-based anticancer treatment by targeted gold nanoparticles 172
Immunological properties of uricase conjugated to neutral soluble polymers 170
Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation 169
Novel Pullulan Bioconjugate for Selective Breast Cancer Bone Metastases Treatment 169
Dexamethasone loaded liposomes by thin‐film hydration and microfluidic procedures: Formulation challenges 169
A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization. 168
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment 165
Thermodynamic analysis of micronization processes from gas-saturated solution 163
Cell up-take control of gold nanoparticles functionalized with a thermoresponsive polymer 163
pH-responsive lipid core micelles for tumour targeting 163
Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery 163
Identification of drugs for Autosomal Dominant Optic Atrophy (ADOA): from ADOA RCGs models to microparticle-based drug delivery in an ADOA mouse model 162
Development and in vivo evaluation of an oral insulin-PEG delivery system 162
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation 162
Glycosilated macromolecular conjugates of antiviral drugs with a polyaspartamide 161
Supramolecular Bioconjugates for Protein and Small Drug Delivery. 161
Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates 160
Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted reat intestinal segments 160
Tailoring surface properties of liposomes for dexamethasone intraocular administration 159
Production of Lipid Microparticles Containing bioactive molecules Functionalized with PEG 159
Tobramycin-loaded complexes to prevent and disrupt Pseudomonas aeruginosa biofilms 159
Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study 158
Covalent modification of mushroom tyrosinase with different amphiphic polymers for pharmaceutical and biocatalysis applications 157
A novel performing PEG-cholane nanoformulation for Amphotericin B delivery 157
Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of “Stealthy” Nanomaterials 156
Avidin bioconjugate with a thermoresponsive polymer for biological and pharmaceutical applications 155
Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine) 155
Thermosensitive "Smart" Surfaces for Biorecognition Based Cell Adhesion and Controlled Detachment 155
Star-like oligo-arginyl-maltotriosyl derivatives as novel cell-penetrating enhancers for the intracellular delivery of colloidal therapeutic systems 154
Chronic systemic curcumin administration antagonizes murine sarcopenia and presarcopenia 154
Cyclodextrin/PEG based hydrogels for multi-drug delivery. 153
Physico-Chemical and Biological Properties of Monofunctional Hydroxy Teriminating Poly(N-Vinylpyrrolidone) Conjugated Superoxide Dismutase 153
Synthesis and characterization of variable conformation pH responsive block co-polymers for nucleic acid delivery and targeted cell entry 153
Polysaccharide based anticancer prodrugs 152
Curcumin-loaded solid lipid particles by PGSS technology 152
pH-sensitive PEG-based micelles for tumor targeting 152
Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process 150
Proteins conjugation with ZnO sol-gel nanopowders 150
Tailored PEG for rh-G-CSF analogue site-specific conjugation. 150
Modified hyaluronic acid derivatives and use thereof 149
Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase 149
Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery 148
Histaminase PEGylation: Preparation and characterization of a new bioconjugate for therapeutic application 148
Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the co-polymer of divinyl ether and maleic anhydride 147
A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation 147
Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats. 147
Bassi polimeri dell'N-acriloil morfolina monofunzionalizzati ad un estremo per la preparazione di coniugati con enzimi, polipeptidi e farmaci 146
Control of peptide aggregation and fibrillation by physical PEGylation 146
Influence of Folate-Targeted Gold Nanoparticles on Subcellular Localization and Distribution into Lysosomes 146
Mannosylated Polycations Target CD206+ Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer Vaccination 145
From Immunosuppression to Immunomodulation – Turning Cold Tumours into Hot 144
Cancer vaccines: an update on recent achievements and prospects for cancer therapy 144
Doxorubicin coupled to lactosaminated albumin: Effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats 143
Optimization of Biomimetic, Leukocyte-Mimicking Nanovesicles for Drug Delivery Against Colorectal Cancer Using a Design of Experiment Approach 140
A Method to maintain the activity in polyethylene glycol-modified proteolytic enzymes 140
Nanotechnologies in protein delivery. 140
POLY(HYDROXYETHYLASPARTAMIDE) DERIVATIVES AS COLLOIDAL DRUG CARRIER SYSTEMS 140
Enhanced biocopmpatibility of polyphosphazenes achieved by radiation grafting 139
Fast atom bombardment in the structural identification of intermediates in the hydrolytic degradation of polyphosphazenes 139
New cyclodextrin bioconjugates for active tumour targeting 139
Polymer coated oncolytic adenovirus to selectively target hepatocellular carcinoma cells 139
In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin 138
Advances in drug delivery and biomaterials: Facts and vision 138
New synthetic polymers for enzyme and liposome modification 137
Sub-unit vaccine against S. aureus-mediated infections: Set-up of nano-sized polymeric adjuvant. 137
Immunogenic and tolerogenic properties of monomethoxypoly(ethylene glycol) conjugated proteins 136
Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers 136
Functionalized polymers to target SerpinB3 in hepatoma cells 136
Novel pH-responsive nanovectors for controlled release of ionisable drugs 135
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 135
Supramolecular association of recombinant human growth hormone with hydrophobized polyhydroxyethylaspartamides 135
Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly(ethylene glycol) 134
Totale 16.379
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.520
article - articoli 81.188
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 4.716
selected - selezionate 0
volume - volumi 3.784
Totale 199.208
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.953 0 0 0 0 0 278 139 249 432 297 341 217
2021/20223.173 77 523 411 157 150 141 119 370 158 96 374 597
2022/20232.743 585 271 96 294 467 303 7 209 313 26 125 47
2023/20241.254 50 215 143 92 65 58 103 77 41 48 171 191
2024/20255.730 33 306 291 193 924 183 272 387 553 222 911 1.455
2025/202612.264 834 2.101 3.216 3.511 2.175 427 0 0 0 0 0 0
Totale 37.123